Codexis (CDXS) Intangibles (2010 - 2016)
Codexis (CDXS) recorded quarterly Intangibles of $281000.0 in Q3 2016, down 75.02% quarter-over-quarter from $1.1 million in Q2 2016, and down 92.31% on a YoY basis from $3.7 million in Q4 2015.
Codexis (CDXS) Intangibles (2010 - 2016) Analysis & Trends
Codexis' Intangibles history runs 7 years deep, the most recent figure standing at $281000.0 for Q3 2016.
- In Q3 2016, Intangibles fell 92.31% year-over-year to $281000.0; the TTM figure through Sep 2016 stood at $281000.0 (down 92.31% YoY), while the FY2015 annual figure was $2.8 million, down 54.54% from the prior year.
- Intangibles was $281000.0 for Q3 2016 at Codexis, down from $1.1 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $15.5 million in Q1 2012 to a low of $281000.0 in Q3 2016.
- Historically, Intangibles has averaged $7.9 million across 5 years, with a median of $7.9 million in 2014.
- The sharpest annual moves came in 2012 and 2016: Intangibles dropped 20.03% in 2012, then tumbled 92.31% in 2016.
- A 5-year view of Intangibles shows it stood at $12.9 million in 2012, then dropped by 26.09% to $9.6 million in 2013, then sank by 35.29% to $6.2 million in 2014, then tumbled by 54.54% to $2.8 million in 2015, then plunged by 90.01% to $281000.0 in 2016.
- The last three Intangibles figures came in at $281000.0 (Q3 2016), $1.1 million (Q2 2016), and $2.0 million (Q1 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 281,000.00 |
| Jun 30, 2016 | 1.13 Mn |
| Mar 31, 2016 | 1.97 Mn |
| Dec 31, 2015 | 2.81 Mn |
| Sep 30, 2015 | 3.66 Mn |
| Jun 30, 2015 | 4.50 Mn |
| Mar 31, 2015 | 5.34 Mn |
| Dec 31, 2014 | 6.19 Mn |
| Sep 30, 2014 | 7.03 Mn |
| Jun 30, 2014 | 7.87 Mn |
| Mar 31, 2014 | 8.72 Mn |
| Dec 31, 2013 | 9.56 Mn |
| Sep 30, 2013 | 10.40 Mn |
| Jun 30, 2013 | 11.25 Mn |
| Mar 31, 2013 | 12.09 Mn |
| Dec 31, 2012 | 12.93 Mn |
| Sep 30, 2012 | 13.78 Mn |
| Jun 30, 2012 | 14.64 Mn |
| Mar 31, 2012 | 15.53 Mn |
| Dec 31, 2011 | 16.44 Mn |